FrieslandCampina Domo and U.S.-based Glycosyn have signed a technology and partnership agreement to develop new infant nutrition ingredients. Glycosyn has developed a patented technology for the production of oligosaccharides from lactose. FrieslandCampina Domo will produce and introduce these new ingredients onto the global market.
“Human Milk Oligosaccharides (HMO’s) are specialized carbohydrates which are naturally prevalent in mother’s milk,” said John R. Garrett, co-CEO, at Glycosyn. “Through our expertise and know-how we have developed technologies which will complement FrieslandCampina’s extensive history and knowledge of infant nutrition ingredients, products, and markets.”
FrieslandCampina Domo is part of FrieslandCampina Ingredients and a worldwide producer of a wide range of ingredients for the infant-, medical-, and cell nutrition markets. Its range of products consists of whey protein concentrates, demineralized whey products, galacto-oligosaccharides, lactose, hydrolysates, encapsulated nutritional oils, and the emerging products which are being developed from the Glycosyn partnership.
